You have 9 free searches left this month | for more free features.

Cardiovascular Reaction

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cardiovascular Toxicity: Comprehensive Myocardial and Vascular

Recruiting
  • Cardiovascular Diseases
  • +7 more
  • Cardiovascular magnetic resonance with stress perfusion
  • +4 more
  • London, United Kingdom
    St Bartholomews Hospital
Sep 15, 2023

Physical Activity Levels and Statin Therapy

Active, not recruiting
  • Cardiovascular Diseases
  • +2 more
  • Physical activity monitoring
  • Nijmegen, Netherlands
    Department of Physiology
Nov 15, 2022

Cardiovascular Drugs Adverse Reaction

Recruiting
  • Pharmacogenetics
  • +2 more
  • Oral Anticoagulant, Direct-Acting
  • Zagreb, Croatia
    UHC Zagreb
Mar 23, 2022

Late Subclinical Cardiovascular Disease in Testicular Cancer

Recruiting
  • Testicular Cancer
  • +7 more
  • Lipid profile
  • +2 more
  • Indianapolis, Indiana
    Indiana University
Nov 7, 2022

Atrial Fibrillation, Anticoagulant Adverse Reaction, Stroke Trial (low-dose rivaroxaban, Standard-dose rivaroxaban)

Not yet recruiting
  • Atrial Fibrillation
  • +3 more
  • low-dose rivaroxaban
  • Standard-dose rivaroxaban
  • (no location specified)
Oct 25, 2023

Stress Reaction Trial in Waco (Low-level laser therapy (LLLT))

Recruiting
  • Stress Reaction
  • Low-level laser therapy (LLLT)
  • Waco, Texas
    Annie T. Ginty
Mar 25, 2022

Screen Time, Performance Enhancing, Injury Prevention Trial (Aerobic exercise)

Completed
  • Screen Time
  • +4 more
  • Aerobic exercise
  • Istanbul, Besiktas, Turkey
    Bahcesehir University
Sep 25, 2022

Colchicine Adverse Reaction, Atrial Fibrillation New Onset Trial in Astrakhan, Moscow (Colchicine Pill, Placebo)

Completed
  • Colchicine Adverse Reaction
  • Atrial Fibrillation New Onset
  • Colchicine Pill
  • Placebo
  • Astrakhan, Russian Federation
  • +1 more
Aug 23, 2022

Liver Transplant; Complications, Renal Insufficiency, Immunosuppressant Adverse Reaction Trial in Edmonton (Envarsus Oral

Suspended
  • Liver Transplant; Complications
  • +4 more
  • Envarsus Oral Product
  • Prograf (SOC)
  • Edmonton, Alberta, Canada
    Univerity of Alberta
Jul 7, 2022

Opioid Analgesic Adverse Reaction Trial in Taiyuan (Esketamine, Sulfentanil or/and Remifentanil)

Recruiting
  • Opioid Analgesic Adverse Reaction
  • Esketamine, Sulfentanil or/and Remifentanil
  • Taiyuan, Shanxi, China
    Zheng Guo
Apr 18, 2022

HIV, Inflammatory Markers, Colchicine Adverse Reaction Trial in Ratchathewi (Low-dose colchicine, Placebo)

Recruiting
  • HIV Infections
  • +2 more
  • Low-dose colchicine
  • Placebo
  • Ratchathewi, ฺBangkok, Thailand
    Angsana Phuphuakrat
Dec 20, 2021

Exercise-induced Muscle Damage in Statin Users

Completed
  • Cardiovascular Diseases
  • +2 more
  • Moderate-intensity exercise
  • Nijmegen, Netherlands
    Department of Physiology
Aug 23, 2021

Mitral Stenosis, Rheumatic Heart Disease, Atrial Fibrillation Trial in Tehran (Rivaroxaban, Warfarin)

Terminated
  • Mitral Stenosis
  • +3 more
  • Tehran, Iran, Islamic Republic of
    Rajaie Cardiovascular Medical and Research Center
Aug 14, 2021

After Gestational Diabetes and Diabetes in Pregnancy

Recruiting
  • Diabetes, Gestational
  • Pregnancy Diabetic
  • Basic data collection (online survey or written form)
  • +3 more
  • Jena, Thüringen, Germany
    Universitätsklinikum Jena
Aug 26, 2021

HIV-1-infection, Antiviral Drug Adverse Reaction, Vascular Diseases Trial in Augusta (Dolutegravir 50 MG, Antiretroviral/Anti

Unknown status
  • HIV-1-infection
  • +7 more
  • Dolutegravir 50 MG
  • Antiretroviral/Anti HIV
  • Augusta, Georgia
    Augusta University
Jan 11, 2021

Chronic Heart Failure, Vitamin D Adverse Reaction Trial in Budapest (Vigantol oil and MCT oil)

Terminated
  • Chronic Heart Failure
  • Vitamin D Adverse Reaction
  • Vigantol oil and MCT oil
  • Budapest, Hungary
  • +1 more
Apr 8, 2021

Precision Treatment With Angiotensin Converting Enzyme Inhibitor

Recruiting
  • Hypertension
  • +2 more
    • Seoul, Korea, Republic of
      Yonsei University Health System, Severance Hospital
    Sep 7, 2022

    Sedentary; Aging Trial in Guangdong (Aerobic Exercise, Time Restricted Fasting)

    Completed
    • Sedentary; Aging
    • Aerobic Exercise
    • Time Restricted Fasting
    • Guangdong, Guangzhou, China
      Guangzhou Sport University
    May 9, 2023

    Arterial Stiffness in Patients With Respiratory Diseases

    Enrolling by invitation
    • Chronic Respiratory Diseases
    • +6 more
    • Breath test using the Compact PTR-TOF-MS
    • +2 more
    • Moscow, Russian Federation
      I.M. Sechenov First Moscow State Medical University (Sechenov Un
    Feb 6, 2023

    Sars-CoV2, Covid19, Cardiovascular Diseases Trial in Barcelona

    Active, not recruiting
    • Sars-CoV2
    • +3 more
      • Barcelona, Catalonia, Spain
        Hospital Clínic of Barcelona
      Aug 22, 2022

      Triglyceride-glucose Index With Cardiac Hemodynamics

      Not yet recruiting
      • Obesity
        • (no location specified)
        Jan 19, 2023

        Lung Cancer, Anesthesia Induction Trial in Shanghai (Dexmedetomidine, Remimazolam tosilate)

        Recruiting
        • Lung Cancer
        • Anesthesia Induction
        • Shanghai, Shanghai, China
          Shanghai Pulmonary Hospital
        Nov 29, 2022

        COVID-19, Endothelial Function, Diastolic Dysfunction Trial in Moscow (Portable cardiac monitor "CardioQvark", Cardiorespiratory

        Recruiting
        • COVID-19
        • +5 more
        • Portable cardiac monitor "CardioQvark"
        • +2 more
        • Moscow, Russian Federation
          I.M. Sechenov First Moscow State Medical University (Sechenov Un
        Nov 5, 2022

        Coronary Artery Disease, Platelet Reactivity Trial in Nieuwegein (Clopidogrel)

        Not yet recruiting
        • Coronary Artery Disease
        • Platelet Reactivity
        • Nieuwegein, Utrecht, Netherlands
        • +1 more
        Dec 9, 2022

        Cardiac Complication, Vascular Diseases Trial in Paris (Cardiac complication induced by VEGF/VEGFR inhibitor)

        Completed
        • Cardiac Complication
        • Vascular Diseases
        • Cardiac complication induced by VEGF/VEGFR inhibitor
        • Paris, France
          AP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, C
        Sep 24, 2019